Anti-S1/RBD-Specific Antibody Formation After SARS-CoV-2 Vaccination in Elderly Rheumatoid Arthritis Patients: Single-Center Prospective Observational Study

CONCLUSION: Our findings suggest that the third dose of the mRNA vaccine could be beneficial in RA patients with risk factors including older age, male sex, and corticosteroid use after two doses of ChAdOx1-S nCoV-19.PMID:37038645 | PMC:PMC10086382 | DOI:10.3346/jkms.2023.38.e109

Source: Journal of Korean Medical Science - April 11, 2023 Category: Biomedical Science Authors: Eun Song Kang Ji Seon Oh Eun-Ju Lee Seokchan Hong Soo Min Ahn Chang-Keun Lee Bin Yoo Yong-Gil Kim Source Type: research